Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3 levels, suggesting these factors might influence male pattern baldness.

Combined finasteride and anastrozole therapy effectively treats BPH, influenced by hormone imbalances and genetics.

Balancing hormones can help women feel youthful and healthy.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

Higher androgen levels do not cause baldness in men.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.